# A Clinical Trial Evaluating the Efficacy and Safety of Leflutrozole on Testicular Function

> **NCT06993155** · PHASE2 · RECRUITING · sponsor: **ReproNovo Aps** · enrollment: 200 (estimated)

## Conditions studied

- Semen Quality

## Interventions

- **DRUG:** Leflutrozole, Dose 1
- **DRUG:** Leflutrozole, Dose 2
- **DRUG:** Leflutrozole, Dose 3
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06993155
- **Lead sponsor:** ReproNovo Aps
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-06-27
- **Primary completion:** 2026-07
- **Final completion:** 2026-11
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2026-02-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06993155

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06993155, "A Clinical Trial Evaluating the Efficacy and Safety of Leflutrozole on Testicular Function". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06993155. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*